We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GT icon
151
Goodyear
GT
$1.89B
$20.3M 0.13%
+1,327,211
New +$22.4M
PPLI
152
People Inc
PPLI
$3.18B
$20M 0.12%
513,272
+387,722
+309% +$15.5M
GRA
153
DELISTED
W.R. Grace & Co.
GRA
$19.7M 0.12%
+259,435
New +$19.4M
INCY icon
154
Incyte
INCY
$23.9B
$19.1M 0.12%
+224,461
New +$18M
AMGN icon
155
Amgen
AMGN
$218B
$19M 0.12%
+103,221
New +$18.5M
WHD icon
156
Cactus
WHD
$5.5B
$19M 0.12%
573,621
+59,597
+12% +$2.07M
SIRI icon
157
SiriusXM
SIRI
$10.1B
$18.6M 0.12%
333,437
-117,881
-26% -$6.71M
SYY icon
158
Sysco
SYY
$40.3B
$18.5M 0.11%
261,467
+181,551
+227% +$12.9M
WUBA
159
DELISTED
58.com Inc
WUBA
$18.5M 0.11%
297,434
-74,510
-20% -$4.8M
ZBH icon
160
Zimmer Biomet
ZBH
$18.7B
$18.3M 0.11%
159,743
+6,507
+4% +$762K
GOOG icon
161
Alphabet (Google) Class C
GOOG
$4.36T
$18.2M 0.11%
336,480
-747,260
-69% -$43.1M
TS icon
162
Tenaris
TS
$26.8B
$17.8M 0.11%
677,683
-9,036
-1% -$242K
CHNG
163
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$17.5M 0.11%
+1,199,500
New +$17.8M
ATR icon
164
AptarGroup
ATR
$8.61B
$17.2M 0.11%
138,253
+63,444
+85% +$7.24M
SLB icon
165
SLB Ltd
SLB
$77.1B
$17.2M 0.11%
431,600
-50,178
-10% -$2.02M
KMX icon
166
CarMax
KMX
$8.26B
$17.1M 0.11%
197,019
+186,148
+1,712% +$14.6M
BKI
167
DELISTED
Black Knight, Inc. Common Stock
BKI
$17.1M 0.11%
283,481
+279,985
+8,009% +$15.9M
PARA
168
DELISTED
Paramount Global Class B
PARA
$16.9M 0.11%
339,440
+164,060
+94% +$8.12M
GRMN
169
Garmin
GRMN
$58.5B
$16.9M 0.1%
211,269
+27,123
+15% +$2.22M
SUPN icon
170
Supernus Pharmaceuticals
SUPN
$2.72B
$16.6M 0.1%
501,783
+275,490
+122% +$9.44M
UNP icon
171
Union Pacific
UNP
$175B
$16.3M 0.1%
96,665
-76,681
-44% -$13.1M
HD icon
172
Home Depot
HD
$347B
$16.2M 0.1%
+77,663
New +$15.5M
MOS icon
173
The Mosaic Company
MOS
$7.37B
$16.1M 0.1%
+641,536
New +$15.7M
XYZ
174
Block Inc
XYZ
$47.1B
$16.1M 0.1%
221,308
+162,685
+278% +$11.4M
EXC icon
175
Exelon
EXC
$46.6B
$16M 0.1%
+466,755
New +$16.5M
5 6
7
8 9

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.